BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2864532)

  • 1. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
    Christiansen C; Riis BJ; Nilas L; Rødbro P; Deftos L
    Lancet; 1985 Oct; 2(8459):800-1. PubMed ID: 2864532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestagen plus cyclical oestrogen for postmenopausal bone loss.
    Selby PL; Peacock M
    Lancet; 1985 Nov; 2(8465):1194-5. PubMed ID: 2865655
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen/progestagen for postmenopausal osteoporosis.
    Stevenson JC; Whitehead MI
    Lancet; 1981 Jul; 2(8238):156. PubMed ID: 6113518
    [No Abstract]   [Full Text] [Related]  

  • 6. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen/gestagen and 24R,25-dihydroxyvitamin D3 therapy on bone formation in postmenopausal women.
    Thomsen K; Riis B; Christiansen C
    J Bone Miner Res; 1986 Dec; 1(6):503-7. PubMed ID: 3332556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
    Bone; 1989; 10(5):313-20. PubMed ID: 2690898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sex hormones on bone in primary osteoporosis.
    Riggs BL; Jowsey J; Kelly PJ; Jones JD; Maher FT
    J Clin Invest; 1969 Jun; 48(6):1065-72. PubMed ID: 5771187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Acta Med Scand; 1985; 218(3):329-33. PubMed ID: 3907290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone loss during oestriol therapy in postmenopausal women.
    Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
    Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of oestrogen and a progestogen on bone loss in postmenopausal women.
    Lindsay R; Hart DM; Purdie D; Ferguson MM; Clark AS; Kraszewski A
    Clin Sci Mol Med; 1978 Feb; 54(2):193-5. PubMed ID: 340117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women.
    Selby PL; Peacock M
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):543-7. PubMed ID: 3113780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal estradiol in the treatment of postmenopausal bone loss.
    Adami S; Suppi R; Bertoldo F; Rossini M; Residori M; Maresca V; Lo Cascio V
    Bone Miner; 1989 Aug; 7(1):79-86. PubMed ID: 2670019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.